{"product_id":"medical-education-resources-internal-medicine-for-primary-care-cardiology-neurology-pain-management-vascular-medicine-2025","title":"Medical Education Resources Internal Medicine for Primary Care Cardiology Neurology Pain Management Vascular Medicine 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: primary care providers and other health professionals with updates in primary care medicine\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eThis program is targeted to office-based primary care providers and other health professionals with updates in primary care medicine\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this program, participants should be better able to:\u003c\/h3\u003e\n\u003cp\u003e– Describe the spectrum of maladies included in peripheral vascular disease\u003c\/p\u003e\n\u003cp\u003e– Discuss presentation and interventional treatment of stroke patients\u003c\/p\u003e\n\u003cp\u003e– List current pharmacologic options for the management of aneurysms\u003c\/p\u003e\n\u003cp\u003e– Describe the evaluation and treatment of venous thrombosis\u003c\/p\u003e\n\u003cp\u003e– Identify strategies to overcome the challenges of treating chronic pain\u003c\/p\u003e\n\u003cp\u003e– Discuss techniques for conducting an efficient physical exam of the low back\u003c\/p\u003e\n\u003cp\u003e– Compare the benefits and side effect profiles of pharmacologic treatment options for fibromyalgia\u003c\/p\u003e\n\u003cp\u003e– Design opioid pain management strategies\u003c\/p\u003e\n\u003cp\u003e– Perform a neurological exam\u003c\/p\u003e\n\u003cp\u003e– Utilize history and physical examination to distinguish weakness from non-specific symptoms\u003c\/p\u003e\n\u003cp\u003e– Discuss evidence-based management options for Alzheimer’s disease\u003c\/p\u003e\n\u003cp\u003e– Evaluate weakness and recognize cardinal features of Parkinson’s disease as well as other movement disorders\u003c\/p\u003e\n\u003cp\u003e– Describe current diagnostic approaches and the role of drug therapy to the patient with acute chest pain\u003c\/p\u003e\n\u003cp\u003e– Implement lifestyle changes as well as lipid and cholesterol guidelines for the prevention of CAD\u003c\/p\u003e\n\u003cp\u003e– Implement treatment strategies reflective of recent guidelines and current evidence based medicine for heart failure\u003c\/p\u003e\n\u003cp\u003e– Explain current concepts in the diagnosis and treatment of hypertension\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThursday, April 10, 2025\u003c\/p\u003e\n\u003cp\u003e7:00 am\u003c\/p\u003e\n\u003cp\u003eRegistration and Breakfast\u003c\/p\u003e\n\u003cp\u003ePeripheral Vascular Disease and Medical Therapy\u003c\/p\u003e\n\u003cp\u003eDefining the spectrum of maladies under the umbrella of Peripheral Vascular Disease including the pathophysiology of atherosclerosis and treatments highlighting lipid lowering agents and antiplatelet therapy\u003c\/p\u003e\n\u003cp\u003eStroke: Initial Presentation to Medical and Surgical Treatment\u003c\/p\u003e\n\u003cp\u003eAn overview of embolic stroke including diagnosis and medical, surgical, and interventional therapy\u003c\/p\u003e\n\u003cp\u003eCoffee Break\u003c\/p\u003e\n\u003cp\u003eAortic and Peripheral Aneurysms\u003c\/p\u003e\n\u003cp\u003eA guide for primary care outlining diagnosis, management, and therapeutic options\u003c\/p\u003e\n\u003cp\u003eChronic Pain Types and Osteoarthritis\u003c\/p\u003e\n\u003cp\u003eChronic pain is much more complex than just acute pain that lasts a long time; The physiology and categorization of chronic pain will be explored; Osteoarthritis has characteristics of more than one category of chronic pain; Characteristics that affect treatment planning\u003c\/p\u003e\n\u003cp\u003eBack Pain\u003c\/p\u003e\n\u003cp\u003eBack pain is a common cause of long term disability; Non-pharmacologic and pharmacologic interventions will be discussed for a variety of causes of back pain including failed back surgery syndrome\u003c\/p\u003e\n\u003cp\u003e12:40 pm\u003c\/p\u003e\n\u003cp\u003eSession Adjourns\u003c\/p\u003e\n\u003cp\u003eFriday, April 11, 2025\u003c\/p\u003e\n\u003cp\u003e7:00 am\u003c\/p\u003e\n\u003cp\u003eRegistration and Breakfast\u003c\/p\u003e\n\u003cp\u003eFibromyalgia and Cannabinoids for Chronic Pain\u003c\/p\u003e\n\u003cp\u003eFibromyalgia is a classic example of the nociplastic chronic pain category; A variety of treatment modalities will be discussed; In addition, the evidence regarding the use of cannabinoids for chronic pain will be presented\u003c\/p\u003e\n\u003cp\u003eSafe Opioid Prescribing\u003c\/p\u003e\n\u003cp\u003eThe role of opioids in the management of chronic pain will be addressed in the contexts of the updated CDC guidelines and the increasing prevalence of opioid use disorder\u003c\/p\u003e\n\u003cp\u003eCoffee Break\u003c\/p\u003e\n\u003cp\u003eManagement of Venous Thrombosis\u003c\/p\u003e\n\u003cp\u003eA discussion focusing on the variety of venous thrombotic diagnoses and the multiple available treatment options\u003c\/p\u003e\n\u003cp\u003ePerforming and Interpreting the Neurological Exam\u003c\/p\u003e\n\u003cp\u003eCharacteristics and objectives of the examination; exam phases; assessing general mental status; long-term predications; examination of infants; demonstration on conducting an exam\u003c\/p\u003e\n\u003cp\u003eA Clinical Approach to Weakness\u003c\/p\u003e\n\u003cp\u003eUsing the history and physical examination to distinguish weakness from non-specific symptoms; characteristics of neurological diseases that produce weakness; presentations of representative diseases of the nervous system\u003c\/p\u003e\n\u003cp\u003e12:40 pm\u003c\/p\u003e\n\u003cp\u003eSession Adjourns\u003c\/p\u003e\n\u003cp\u003eSaturday, April 12, 2025\u003c\/p\u003e\n\u003cp\u003e7:00 am\u003c\/p\u003e\n\u003cp\u003eRegistration and Breakfast\u003c\/p\u003e\n\u003cp\u003eAlzheimer’s \u0026amp; Other Dementias\u003c\/p\u003e\n\u003cp\u003eDefinition; statistics; neurological changes of normal aging; pathology; etiological theories; vascular dementias; investigations; social issues; symptomatic treatment; research therapies\u003c\/p\u003e\n\u003cp\u003eParkinson’s Disease \u0026amp; Other Movement Disorders\u003c\/p\u003e\n\u003cp\u003eEpidemiology; cardinal features; secondary features; pathology; neurochemistry; differential diagnosis; treatment; complication; other movement disorders; neuroleptic- induced movement disorders; chorea\u003c\/p\u003e\n\u003cp\u003eCoffee Break\u003c\/p\u003e\n\u003cp\u003eAcute Coronary Syndromes: The Patient with Acute Chest Pain\u003c\/p\u003e\n\u003cp\u003eDiagnosis and initial evaluation in the primary care setting, urgent care clinic and emergency department; Initial workup, treatment, and follow-up; Diagnosing and treating ST segment elevation and non-ST segment elevation MIs; The role of drug therapy–primary vs adjunctive to PCI; Follow up after acute coronary syndromome\u003c\/p\u003e\n\u003cp\u003ePrimary \u0026amp; Secondary Prevention of CAD\u003c\/p\u003e\n\u003cp\u003eDefinitions; AHA\/ACC and other lipid guidelines updates; HDL Cholesterol: The good cholesterol?; Metabolic syndrome and\/or obesity; Who needs treatment and how much; The role of lifestyle changes, exercise and cardiac rehabilitation; Drug therapy updates; Risk calculation\u003c\/p\u003e\n\u003cp\u003e11:40 am\u003c\/p\u003e\n\u003cp\u003eSession Adjourns\u003c\/p\u003e\n\u003cp\u003eSunday, April 13, 2025\u003c\/p\u003e\n\u003cp\u003e7:00 am\u003c\/p\u003e\n\u003cp\u003eRegistration and Breakfast\u003c\/p\u003e\n\u003cp\u003eHeart Failure\u003c\/p\u003e\n\u003cp\u003eEtiologies and stages of heart failure; ACC\/AHA Heart Failure Guidelines; Heart failure with reduced EF (HFrEF) and heart failure with preserved EF (HFpEF); Determining patients for referral using biomarkers, eg NT Pro BNP; Treatment options: ACE inhibitors, ARBs, ARNI, beta blockers, mineralocorticoid receptor antagonists, SGLT2i; The role of devices in treatment and antiplatelet drugs; Issues related to the hospitalized patient with acute decompensated heart failure and readmissions\u003c\/p\u003e\n\u003cp\u003eHypertension\u003c\/p\u003e\n\u003cp\u003eThe 2017 AHA\/ACC Hypertension Guidelines; The 2024 ESC Guidelines for hypertension; Approaches to treatment thresholds and goals; Choices for initial and combination therapy; Resistant hypertension; Treating special populations: diabetics, the elderly, patients with renal failure\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405727617220,"sku":null,"price":156.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Medical-Education-Resources-Internal-Medicine-for-Primary-Care-Cardio-Neuro-Pain-Vasc-2025.jpg?v=1784215418","url":"https:\/\/medicalcoursespro.com\/products\/medical-education-resources-internal-medicine-for-primary-care-cardiology-neurology-pain-management-vascular-medicine-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}